GOLDMAN SACHS GROUP INC - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 50 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$53,834
-56.8%
13,857
-35.8%
0.00%
Q2 2023$124,603
-72.7%
21,595
-69.2%
0.00%
Q1 2023$456,073
+794.3%
70,165
+298.8%
0.00%
Q3 2022$51,000
-16.4%
17,594
-44.6%
0.00%
Q2 2022$61,000
-30.7%
31,750
+193.9%
0.00%
Q1 2022$88,000
-83.4%
10,802
-67.7%
0.00%
Q4 2019$531,000
+42.4%
33,393
+32.2%
0.00%
Q3 2019$373,000
-62.7%
25,254
-50.2%
0.00%
Q2 2018$1,001,00050,7140.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 108,794$1,252,0000.47%
Perceptive Advisors 3,410,412$39,254,0000.42%
KNOTT DAVID M 76,585$881,0000.40%
Fosun International Ltd 324,061$3,730,0000.24%
Orbimed Advisors 1,479,733$17,032,0000.15%
SteelPeak Wealth, LLC 132,961$1,530,0000.14%
KORNITZER CAPITAL MANAGEMENT INC /KS 665,511$7,660,0000.13%
Capital Investment Advisory Services, LLC 15,125$174,0000.03%
BECK MACK & OLIVER LLC 10,000$115,0000.00%
MILLENNIUM MANAGEMENT LLC 335,318$3,860,0000.00%
View complete list of VERRICA PHARMACEUTICALS INC shareholders